Pharmanex Cholestin public health benefit potential noted by Sen. Harkin in letter to FDA.
This article was originally published in The Tan Sheet
Executive Summary
CHOLESTIN PUBLIC HEALTH BENEFIT POTENTIAL NOTED BY SEN. HARKIN in a Jan. 16 letter to FDA. Tom Harkin (D-Iowa) suggests "the public health factor should be weighed heavily in any decision regarding implementation" of the Dietary Supplement Health & Education Act. "In this case, there appears to be considerable evidence and expert judgment that Cholestin can serve an important health promotion purpose." FDA is expected to make a decision in the near future on whether Pharmanex may continue to market the red yeast rice product as a dietary supplement for healthy cholesterol levels.